| Pharmaceutical active ingredients: |
| Sitagliptin Phosphate Monohydrate |
| Available forms, composition and doses of Xelevia: |
| Tablets, Film-Coated; Oral; Sitagliptin Phosphate Monohydrate 100 mg |
| Xelevia medical category: |
| Human:Antidiabetic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10BH01 - Sitagliptin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pierre Fabre |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Urosiphon | Orthosiphon Fluid Extract | Pierre Fabre |
| Vagantyl | Homatropine Methylbromide; Scopolamine Oxide Hydrobromide; Vitamin B6 (Pyridoxine Hydrochloride) | Pierre Fabre |
| Velmetia | Metformin Hydrochloride; Sitagliptin Phosphate Monohydrate | Pierre Fabre |
| Veybirol-Tyrothyricine | Formaldehyde; Tyrothricin | Pierre Fabre |
| Vira-MP | Vidarabine Sodium Phosphate | Pierre Fabre |
| Ystheal | Vitamin A (Retinal) | Pierre Fabre; Silesia Laboratorios |
| ZyrtecSet | Cetirizine Hydrochloride | Pierre Fabre |
| Friljet | Cryofluorane | Pierre Rolland Laboratoire |
| Mepacyl | Dexamethasone Acetate; Metacresol Acetate; Parachlorophenol | Pierre Rolland Laboratoire |
| Osomol 3 | Formaldehyde; Guaiacol | Pierre Rolland Laboratoire |